Come up with a name for your new list and we'll add to it:
Biokine Therapeutics raised a round of funding on , . Investors include
Clal Biotechnology Industries.
Biokine Therapeutics is focused on developing novel anti-cancer and stem cells mobilization drugs to treat cancer patients. Biokine targets CXCR4 chemokine receptor, which is critical to the developme…